 | • レポートコード：MRC2102QY9666 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の神経弛緩薬市場について種類別（ドロペリドール、ミダゾラム）、用途別（医療、科学研究、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・神経弛緩薬市場の概要 ・世界の主要地域別神経弛緩薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の神経弛緩薬市場規模2015-2026：種類別（ドロペリドール、ミダゾラム） ・世界の神経弛緩薬市場規模2015-2026：用途別（医療、科学研究、その他） ・神経弛緩薬の米国市場規模2015-2020 ・神経弛緩薬のヨーロッパ市場規模2015-2020 ・神経弛緩薬の中国市場規模2015-2020 ・神経弛緩薬の日本市場規模2015-2020 ・神経弛緩薬の東南アジア市場規模2015-2020 ・神経弛緩薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・神経弛緩薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・神経弛緩薬の市場動向・機会・課題 ・調査の結論 |
Analgesics mainly work in the central or peripheral nervous system, selective inhibition and relief of a variety of pain, pain relief and fear of tension and anxiety pain drugs.
Market Analysis and Insights: Global Neuroleptic Market
The global Neuroleptic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Neuroleptic Scope and Market Size
The global Neuroleptic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroleptic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Neuroleptic market is segmented into
Droperidol
Midazolam
Segment by Application, the Neuroleptic market is segmented into
Medical Care
Scientific Research
Others
The Neuroleptic market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuroleptic market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neuroleptic Market Share Analysis
Neuroleptic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuroleptic business, the date to enter into the Neuroleptic market, Neuroleptic product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnso
Pfizer
Eli Lilly
Bristol-Myers Squibb
GlaxoSmithKline
1 Neuroleptic Market Overview
1.1 Neuroleptic Product Scope
1.2 Neuroleptic Segment by Type
1.2.1 Global Neuroleptic Sales by Type (2020-2026)
1.2.2 Droperidol
1.2.3 Midazolam
1.3 Neuroleptic Segment by Application
1.3.1 Global Neuroleptic Sales Comparison by Application (2020-2026)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Neuroleptic Market Estimates and Forecasts (2015-2026)
1.4.1 Global Neuroleptic Sales Growth Rate (2015-2026)
1.4.2 Global Neuroleptic Revenue and Growth Rate (2015-2026)
1.4.3 Global Neuroleptic Price Trends (2015-2026)
2 Neuroleptic Estimate and Forecast by Region
2.1 Global Neuroleptic Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Neuroleptic Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Neuroleptic Sales Market Share by Region (2015-2020)
2.2.2 Global Neuroleptic Revenue Market Share by Region (2015-2020)
2.3 Global Neuroleptic Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Neuroleptic Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Neuroleptic Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Neuroleptic Estimates and Projections (2015-2026)
2.4.2 Europe Neuroleptic Estimates and Projections (2015-2026)
2.4.3 China Neuroleptic Estimates and Projections (2015-2026)
2.4.4 Japan Neuroleptic Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Neuroleptic Estimates and Projections (2015-2026)
2.4.6 India Neuroleptic Estimates and Projections (2015-2026)
3 Global Neuroleptic Competition Landscape by Players
3.1 Global Top Neuroleptic Players by Sales (2015-2020)
3.2 Global Top Neuroleptic Players by Revenue (2015-2020)
3.3 Global Neuroleptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroleptic as of 2019)
3.4 Global Neuroleptic Average Price by Company (2015-2020)
3.5 Manufacturers Neuroleptic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Neuroleptic Players (Opinion Leaders)
4 Global Neuroleptic Market Size by Type
4.1 Global Neuroleptic Historic Market Review by Type (2015-2020)
4.1.1 Global Neuroleptic Sales Market Share by Type (2015-2020)
4.1.2 Global Neuroleptic Revenue Market Share by Type (2015-2020)
4.1.3 Global Neuroleptic Price by Type (2015-2020)
4.2 Global Neuroleptic Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Neuroleptic Sales Forecast by Type (2021-2026)
4.2.2 Global Neuroleptic Revenue Forecast by Type (2021-2026)
4.2.3 Global Neuroleptic Price Forecast by Type (2021-2026)
5 Global Neuroleptic Market Size by Application
5.1 Global Neuroleptic Historic Market Review by Application (2015-2020)
5.1.1 Global Neuroleptic Sales Market Share by Application (2015-2020)
5.1.2 Global Neuroleptic Revenue Market Share by Application (2015-2020)
5.1.3 Global Neuroleptic Price by Application (2015-2020)
5.2 Global Neuroleptic Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Neuroleptic Sales Forecast by Application (2021-2026)
5.2.2 Global Neuroleptic Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuroleptic Price Forecast by Application (2021-2026)
6 United States Neuroleptic Market Facts & Figures
6.1 United States Neuroleptic Sales Market Share by Company (2015-2020)
6.2 United States Neuroleptic Sales Market Share by Type (2015-2020)
6.3 United States Neuroleptic Sales Market Share by Application (2015-2020)
7 Europe Neuroleptic Market Facts & Figures
7.1 Europe Neuroleptic Sales Market Share by Company (2015-2020)
7.2 Europe Neuroleptic Sales Market Share by Type (2015-2020)
7.3 Europe Neuroleptic Sales Market Share by Application (2015-2020)
8 China Neuroleptic Market Facts & Figures
8.1 China Neuroleptic Sales Market Share by Company (2015-2020)
8.2 China Neuroleptic Sales Market Share by Type (2015-2020)
8.3 China Neuroleptic Sales Market Share by Application (2015-2020)
9 Japan Neuroleptic Market Facts & Figures
9.1 Japan Neuroleptic Sales Market Share by Company (3015-3030)
9.2 Japan Neuroleptic Sales Market Share by Type (2015-2020)
9.3 Japan Neuroleptic Sales Market Share by Application (2015-2020)
10 Southeast Asia Neuroleptic Market Facts & Figures
10.1 Southeast Asia Neuroleptic Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Neuroleptic Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Neuroleptic Sales Market Share by Application (2015-2020)
11 India Neuroleptic Market Facts & Figures
11.1 India Neuroleptic Sales Market Share by Company (2015-2020)
11.2 India Neuroleptic Sales Market Share by Type (2015-2020)
11.3 India Neuroleptic Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Neuroleptic Business
12.1 Johnson & Johnso
12.1.1 Johnson & Johnso Corporation Information
12.1.2 Johnson & Johnso Business Overview
12.1.3 Johnson & Johnso Neuroleptic Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnso Neuroleptic Products Offered
12.1.5 Johnson & Johnso Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Neuroleptic Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Neuroleptic Products Offered
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Business Overview
12.3.3 Eli Lilly Neuroleptic Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly Neuroleptic Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Business Overview
12.4.3 Bristol-Myers Squibb Neuroleptic Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Neuroleptic Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Neuroleptic Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Neuroleptic Products Offered
12.5.5 GlaxoSmithKline Recent Development
…
13 Neuroleptic Manufacturing Cost Analysis
13.1 Neuroleptic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neuroleptic
13.4 Neuroleptic Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neuroleptic Distributors List
14.3 Neuroleptic Customers
15 Market Dynamics
15.1 Neuroleptic Market Trends
15.2 Neuroleptic Opportunities and Drivers
15.3 Neuroleptic Market Challenges
15.4 Neuroleptic Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neuroleptic Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Neuroleptic Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Neuroleptic Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Neuroleptic Sales (MT) by Region (2015-2020)
Table 5. Global Neuroleptic Sales Market Share by Region (2015-2020)
Table 6. Global Neuroleptic Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Neuroleptic Revenue Share by Region (2015-2020)
Table 8. Global Neuroleptic Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Neuroleptic Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Neuroleptic Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Neuroleptic Revenue Share Forecast by Region (2021-2026)
Table 12. Global Neuroleptic (MT) of Key Companies (2015-2020)
Table 13. Global Neuroleptic Sales Share by Company (2015-2020)
Table 14. Global Neuroleptic Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Neuroleptic Revenue Share by Company (2015-2020)
Table 16. Global Neuroleptic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroleptic as of 2019)
Table 17. Global Neuroleptic Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Neuroleptic Manufacturing Sites and Area Served
Table 19. Manufacturers Neuroleptic Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Neuroleptic Players
Table 22. Global Neuroleptic Sales (MT) by Type (2015-2020)
Table 23. Global Neuroleptic Sales Share by Type (2015-2020)
Table 24. Global Neuroleptic Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Neuroleptic Price (MT) by Type (2015-2020)
Table 26. Global Neuroleptic Sales Share by Type (2021-2026)
Table 27. Global Neuroleptic Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Neuroleptic Revenue Share by Type (2021-2026)
Table 29. Global Neuroleptic Price (MT) by Type (2021-2026)
Table 30. Global Neuroleptic Sales (MT) by Application (2015-2020)
Table 31. Global Neuroleptic Sales Share by Application (2015-2020)
Table 32. Global Neuroleptic Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Neuroleptic Price (MT) by Application (2015-2020)
Table 34. Global Neuroleptic Sales (MT) by Application (2021-2026)
Table 35. Global Neuroleptic Sales Share by Application (2021-2026)
Table 36. Global Neuroleptic Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Neuroleptic Revenue Share by Application (2021-2026)
Table 38. Global Neuroleptic Price (MT) by Application (2021-2026)
Table 39. United States Neuroleptic Sales (MT) by Company (2015-2020)
Table 40. United States Neuroleptic Sales Market Share by Company (2015-2020)
Table 41. United States Neuroleptic Sales (MT) by Type (2015-2020)
Table 42. United States Neuroleptic Sales Market Share by Type (2015-2020)
Table 43. United States Neuroleptic Sales (MT) by Application (2015-2020)
Table 44. United States Neuroleptic Sales Market Share by Application (2015-2020)
Table 45. Europe Neuroleptic Sales (MT) by Company (2015-2020)
Table 46. Europe Neuroleptic Sales Market Share by Company (2015-2020)
Table 47. Europe Neuroleptic Sales (MT) by Type (2015-2020)
Table 48. Europe Neuroleptic Sales Market Share by Type (2015-2020)
Table 49. Europe Neuroleptic Sales (MT) by Application (2015-2020)
Table 50. Europe Neuroleptic Sales Market Share by Type (2015-2020)
Table 51. China Neuroleptic Sales (MT) by Company (2015-2020)
Table 52. China Neuroleptic Sales Market Share by Company (2015-2020)
Table 53. China Neuroleptic Sales (MT) by Type (2015-2020)
Table 54. China Neuroleptic Sales Market Share by Type (2015-2020)
Table 55. China Neuroleptic Sales (MT) by Application (2015-2020)
Table 56. China Neuroleptic Sales Market Share by Application (2015-2020)
Table 57. Japan Neuroleptic Sales (MT) by Company (2015-2020)
Table 58. Japan Neuroleptic Sales Market Share by Company (2015-2020)
Table 59. Japan Neuroleptic Sales (MT) by Type (2015-2020)
Table 60. Japan Neuroleptic Sales Market Share by Type (2015-2020)
Table 61. Japan Neuroleptic Sales (MT) by Application (2015-2020)
Table 62. Japan Neuroleptic Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Neuroleptic Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Neuroleptic Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Neuroleptic Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Neuroleptic Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Neuroleptic Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Neuroleptic Sales Market Share by Application (2015-2020)
Table 69. India Neuroleptic Sales (MT) by Company (2015-2020)
Table 70. India Neuroleptic Sales Market Share by Company (2015-2020)
Table 71. India Neuroleptic Sales (MT) by Type (2015-2020)
Table 72. India Neuroleptic Sales Market Share by Type (2015-2020)
Table 73. India Neuroleptic Sales (MT) by Application (2015-2020)
Table 74. India Neuroleptic Sales Market Share by Application (2015-2020)
Table 75. Johnson & Johnso Corporation Information
Table 76. Johnson & Johnso Description and Business Overview
Table 77. Johnson & Johnso Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Johnson & Johnso Neuroleptic Product
Table 79. Johnson & Johnso Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Neuroleptic Product
Table 84. Pfizer Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Eli Lilly Neuroleptic Product
Table 89. Eli Lilly Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Neuroleptic Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Neuroleptic Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Neuroleptic Distributors List
Table 103. Neuroleptic Customers List
Table 104. Neuroleptic Market Key Trends
Table 105. Neuroleptic Key Opportunities and Drivers
Table 106. Neuroleptic Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuroleptic Product Picture
Figure 2. Global Neuroleptic Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neuroleptic Market Share by Application in 2020 & 2026
Figure 6. Medical Care Examples
Figure 7. Scientific Research Examples
Figure 8. Others Examples
Figure 9. Global Neuroleptic Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Neuroleptic Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Neuroleptic Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Neuroleptic Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Neuroleptic Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Neuroleptic Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Neuroleptic Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Neuroleptic Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Neuroleptic Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Neuroleptic Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Neuroleptic Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Neuroleptic Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Neuroleptic Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Neuroleptic Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Neuroleptic Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Neuroleptic Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Neuroleptic Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Neuroleptic Players Market Share by Revenue in Neuroleptic 2015 & 2019
Figure 27. Neuroleptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Neuroleptic Revenue Share by Type (2015-2020)
Figure 29. Global Neuroleptic Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Neuroleptic Revenue Share by Application (2015-2020)
Figure 31. Global Neuroleptic Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Neuroleptic Sales Market Share by Type in 2019
Figure 33. United States Neuroleptic Sales Market Share by Type in 2019
Figure 34. Europe Neuroleptic Sales Market Share by Company in 2019
Figure 35. Europe Neuroleptic Sales Market Share by Type in 2019
Figure 36. Europe Neuroleptic Sales Market Share by Application in 2019
Figure 37. China Neuroleptic Sales Market Share by Company in 2019
Figure 38. China Neuroleptic Sales Market Share by Type in 2019
Figure 39. China Neuroleptic Sales Market Share by Application in 2019
Figure 40. Japan Neuroleptic Sales Market Share by Company in 2019
Figure 41. Japan Neuroleptic Sales Market Share by Type in 2019
Figure 42. Japan Neuroleptic Sales Market Share by Application in 2019
Figure 43. Southeast Asia Neuroleptic Sales Market Share by Company in 2019
Figure 44. Southeast Asia Neuroleptic Sales Market Share by Type in 2019
Figure 45. Southeast Asia Neuroleptic Sales Market Share by Application in 2019
Figure 46. India Neuroleptic Sales Market Share by Company in 2019
Figure 47. India Neuroleptic Sales Market Share by Type in 2019
Figure 48. India Neuroleptic Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Neuroleptic
Figure 51. Manufacturing Process Analysis of Neuroleptic
Figure 52. Neuroleptic Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
心臓治療用医療機器の世界市場レポート2020 Cardiac Care Medical Equipment is the equipment used for cardiac care. The robust line of cardiac care products include Cardiac Monitors, EKG (Electrocardiogram) Equipment, Heart-Lung Bypass Machines, Stress Test Systems, Intra-Aortic Balloon Pumps, Infusion Pumps, AEDs and Defibrillators, and more.…- 新生児（早産）ケアの世界市場レポート2020 Neonatal (preterm) infant care forms a significant part of the pediatric healthcare market in the global as neonatal (preterm) births are one of the leading causes of infant mortality in the worldwide. The top 3 manufacturers held about 57.26% of the market share, in terms of the globle revenue in 2…
- 急性期人工呼吸器の世界市場レポート2020 When it comes to critical care transportation, one of the key pieces of equipment to have on-hand is a portable ventilator. In addition to oxygenation, perfusion, and circulation, ventilation is one of the vital functions that must be sustained while transporting a patient to a critical care facilit…
- 急性期治療用ニードルレスコネクタの世界市場レポート2020 Acute Care Needleless connectors are utilized to connect catheters to syringes or IV systems and acute care needleless connectors allow the easy administration of medicines as well as convenient withdrawal of blood intravenously. In the last several years, Global market of Acute Care Needleless Conn…
- 亜急性期用人工呼吸器の世界市場レポート2020 Market Analysis and Insights: Global Sub-acute Care Ventilators Market The global Sub-acute Care Ventilators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Sub-acute Care Ventilators Scope and Market Size The global Su…